Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
10/2003
10/08/2003EP1349485A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003CN1446582A Preparation for eyes
10/07/2003US6630574 Compositions and methods for the therapy and diagnosis of lung cancer
10/07/2003US6630313 Phosphatidyl serine receptors and uses thereof
10/07/2003US6630304 Human osteoporosis gene
10/07/2003US6630298 HCV antigen/antibody combination assay
10/07/2003CA2132540C A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
10/07/2003CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080676A1 Antibody against transferrin-containing immune complex, process for producing the antibody, hybridoma and immunoassay method
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080655A1 A mutated immunoglobulin-binding protein
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080569A2 Egfr ligands and methods of use
10/02/2003WO2003020938A3 Method of protein production in plants
10/02/2003WO2003016535A3 Novel amylases and uses thereof
10/02/2003WO2003006493A3 Histidine phosphatase interacting protein with 180kd
10/02/2003WO2002022809A3 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
10/02/2003WO2002002623A3 Compositions and methods for the therapy and diagnosis of lung cancer
10/02/2003US20030188335 Chimeric & endotoxin protein with extraordinarily high insecticidal activity
10/02/2003US20030187224 Chimeric OPG polypeptides
10/02/2003US20030186874 Genetic enhancers comprising amino acid sequences derived from retrovirus envelope proteins coupled to core peptides, used as drugs having improve half life
10/02/2003US20030186851 Binding of a proteinaceous substance to cell-wall material of a Gram-positive bacterium
10/02/2003US20030186841 Ligand activated transcriptional regulator proteins
10/02/2003US20030186385 Method of identifying polypeptide monobodies which bind to target proteins and use thereof
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186275 Using bacterial peptides to develop vaccine to protect against mycobacterium infections
10/02/2003US20030186264 Comprises enzymatic polypeptide for diagnosis and treatment of genetic disorders; drug screening; immunoassay; high throughput assay
10/02/2003US20030186232 Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof
10/02/2003US20030186229 Emission ratiometric indicators of phosphorylation
10/02/2003US20030185862 Fusion peptide of human type- I collagen derived peptide and Tat peptide, preparation therof, and skin anti-aging cosmetic composition comprising the same
10/02/2003US20030185845 Such as variants of interleukin 5 and tumour necrosis factor alpha
10/02/2003US20030185842 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185825 Novel immunotoxins and methods of inducing immune tolerance
10/02/2003US20030185824 Administering an inhibitor of the CD2/LFA-3 interaction, in combination with an auxiliary agent, such as UV-B
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003CA2479896A1 A mutated immunoglobulin-binding protein
10/02/2003CA2479732A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003CA2479306A1 Egfr ligands and methods of use
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348029A2 Materials and methods relating to protein aggregation in neurodegenerative disease
10/01/2003EP1347992A2 Polymorphic bone morphogenetic protein 2
10/01/2003EP1347770A2 Method of making a protein polymer and uses of the polymer
10/01/2003EP1347730A2 Recombinant anti-cd30 antibodies and uses thereof
10/01/2003EP1100830B1 Heterominibodies
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1444992A Method and combination for treating tumors based on ERBB-3
10/01/2003CN1122718C Botulinum toxin derivatives able to modify peripheral sensory afferent functions
10/01/2003CN1122532C Pigment marked protein composite and its preparing method
09/2003
09/30/2003US6627424 Protein comprising a sequence non-specific binding domain and a DNA polymerase domain; enhances binding and catalytic activity
09/30/2003US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/30/2003US6627202 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
09/25/2003WO2003078614A2 Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants
09/25/2003WO2003078470A1 Fusion peptide grafted with tat peptide to human type-i collagen derived peptide, its preparation method, and cosmetic composition for anti-aging comprising the same
09/25/2003WO2003078457A1 MUTEINS OF THE C5a ANAPHYLATOXIN, NUCLEIC ACID MOLECULES ENCODING SUCH MUTEINS, AND PHARMACEUTICAL USES OF MUTEINS OF THE C5a ANAPHYLATOXIN
09/25/2003WO2003078453A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
09/25/2003WO2003077863A2 Method for overexpression of zwitterionic polysaccharides
09/25/2003WO2003040313A3 Il-21 antagonists
09/25/2003WO2003011331A3 Materials and methods relating to improved vaccination strategies
09/25/2003WO2003008454A3 Glycoprotein vi fusion proteins
09/25/2003WO2002097059A9 Chromosome-based platforms
09/25/2003WO2002064634A3 Human monoclonal antibodies to fc alpha receptor (cd89)
09/25/2003WO2002064612A9 Human g-protein chemokine receptor (ccr5) hdgnr10
09/25/2003WO2002063004A3 G-protein coupled receptors
09/25/2003WO2002014489A9 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
09/25/2003US20030181379 Novel fibroblast growth factor (FGF23) and methods for use
09/25/2003US20030180925 Elution in the presence of a metal chelate solid supports
09/25/2003US20030180816 Method to provide bacterial ghosts provided with antigens
09/25/2003US20030180799 Antibodies against plasma cells
09/25/2003US20030180752 Type 2 cytokine receptor and nucleic acids encoding same
09/25/2003US20030180742 A polypetide; catalyzes the hydrolysis of epoxides and arene oxides to their corresponding diols
09/25/2003US20030180326 Methods and compositions for impairing multiplication of HIV-1
09/25/2003US20030180307 Polypeptides; detecting infections using antibodies
09/25/2003US20030180303 Lipopolysaccharide binding protein derivatives
09/25/2003US20030180285 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti hsp90 antibodies
09/25/2003CA2819867A1 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants
09/25/2003CA2479246A1 Method for overexpression of zwitterionic polysaccharides
09/25/2003CA2479118A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
09/25/2003CA2478294A1 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants
09/24/2003EP1346731A1 Conjugates for treating inflammatory disorders and associated tissue damage
09/24/2003EP1346217A2 Reversible mhc multimer staining for functional purification of antigen-specific t cells
09/24/2003EP1346058A2 Adenoviral systems and the uses thereof
09/24/2003EP1346056A1 Methods for the production of multimeric proteins, and related compositions
09/24/2003EP1346041A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
09/24/2003EP1345969A2 Anti-cd28 antibody
09/24/2003EP1345961A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same
09/24/2003EP1345959A2 Membrane scaffold proteins
09/24/2003EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences
09/24/2003EP1345627A1 Targeted modification of intracellular compounds
09/24/2003EP1345625A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
09/24/2003CN1444656A High level production of P-hydroxybenzoic acid in green plants
09/24/2003CN1444652A Mammalian receptor proteins, related regents and methods
09/24/2003CN1444602A Human receptor proteins, related reagents and methods
1 ... 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 ... 295